| Literature DB >> 35684050 |
Wei-Yi Cheng1, Wan-Ju Yeh2, Jung Ko3, Ya-Ling Huang4, Hsin-Yi Yang5.
Abstract
Obesity is a major public health concern worldwide with a rising prevalence. Diets containing whole grains have been demonstrated to benefit body composition and inflammatory conditions in individuals at a high risk of metabolic disorders. This study investigated the effects of dehulled adlay on blood lipids and inflammation in overweight and obese adults. We recruited 21 individuals with abdominal obesity to participate in a 6-week experiment, providing them 60 g of dehulled adlay powder per day as a substitute for their daily staple. Before and after the 6-week intervention, we performed anthropometric analyses and measured blood lipid profiles, adipokines, and markers of inflammation. At the end of the study, the percentage of body fat mass, blood total cholesterol, and triglyceride levels were significantly decreased compared with the baseline. Plasma tumor necrosis factor alpha, interleukin-6, leptin, and malondialdehyde levels were also reduced. In addition, participants with higher basal blood lipid levels exhibited enhanced lipid lowering effects after the dehulled adlay intervention. These results suggest that a dietary pattern containing 60 g of dehulled adlay per day may have a beneficial effect on lipid profiles and inflammatory markers in individuals that are overweight and obese.Entities:
Keywords: dehulled adlay; inflammation; lipids; obesity; overweight
Mesh:
Substances:
Year: 2022 PMID: 35684050 PMCID: PMC9182814 DOI: 10.3390/nu14112250
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Flow chart of the study protocol. BW, body weight; IBW, ideal body weight; DM, diabetic mellitus; and CVD, cardiovascular disease.
Anthropometric, blood lipid, and inflammatory parameters for all participants (n = 21) at baseline and the end of the study.
| Parameters | W0 | W6 |
|---|---|---|
| Height (cm) | 162.3 ± 7.4 | |
| Weight (kg) | 78.5 ± 9.1 | 78.6 ± 8.9 |
| Fat mass (%) | 40.9 ± 6.9 | 37.7 ± 6.0 * |
| BMI | 29.8 ± 3.2 | 29.9 ± 2.9 |
| Waist (cm) | 92.0 ± 7.0 | 90.4 ± 8.4 |
| Hip (cm) | 108.9 ± 5.7 | 108.2 ± 4.7 |
| WHR | 0.8 ± 0.1 | 0.8 ± 0.1 |
| Tricep (mm) | 27.7 ± 6.4 | 25.5 ± 4.2 |
| Fasting glucose (mg/dL) | 93.8 ±16.5 | 91.6 ± 8.2 |
| C-peptide (ng/dL) | 2.0 ± 0.5 | 2.3 ± 0.4 * |
| HbA1c (%) | 5.4 ± 0.9 | 5.3 ± 0.6 |
| TC (mg/dL) | 180.1 ± 34.5 | 170.8 ± 32.3 * |
| TG (mg/dL) | 114.0 ± 52.3 | 95.4 ± 43.1 * |
| HDL-C (mg/dL) | 45.8 ± 8.0 | 46.3 ± 9.0 |
| LDL-C (mg/dL) | 105.7 ± 29.6 | 101.5 ± 30.2 |
| AST (U/L) | 20.9 ± 9.0 | 20.6 ± 12.1 |
| ALT (U/L) | 28.7 ± 49.3 | 32.7 ± 56.8 * |
| hsCRP (mg/L) | 1.88 ± 1.56 | 2.42 ± 3.38 |
Values are presented as mean ± SD. Paired t-test was used to compare baseline and end-of-the study measurements. * Significant differences: p < 0.05. BMI, body mass index; WHR, waist-to-hip ratio; HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol, AST, aspartate aminotransferase; ALT, alanine aminotransferase; and hsCRP, high-sensitivity C-reactive protein.
Change in blood lipid and inflammatory parameters after the 6-week experimental period according to sex.
| Parameters | Change of Parameters | |
|---|---|---|
| Women ( | Men ( | |
| Body weight (kg) | −0.7 ± 2.0 | 2.2 ± 3.0 * |
| Fat mass (%) | −3.0 ± 3.8 | −0.3 ± 4.4 |
| Fasting glucose (mg/dL) | −3.6 ± 11.8 | 1.5 ± 2.4 |
| C-peptide (ng/dL) | 0.2 ± 0.5 | 0.5 ± 0.8 |
| HbA1c (%) | −0.2 ± 0.4 | 0.0 ± 0.2 |
| TC (mg/dL) | −13.5 ± 21.7 | 1.3 ± 12.8 |
| TG (mg/dL) | −11.5 ± 37.2 | −36.5 ± 21.3 |
| HDL-C (mg/dL) | 0.5 ± 5.7 | 0.5 ± 8.0 |
| LDL-C (mg/dL) | −8.1 ± 18.2 | 5.7 ± 11.9 |
| AST (U/L) | −1.0 ± 3.6 | 1.7 ± 6.2 |
| ALT (U/L) | 1.6 ± 3.4 | 10.2 ± 14.2 |
| hsCRP (mg/L) | −0.09 ± 1.46 | 2.13 ± 5.61 |
Values are presented as mean ± SD. Unpaired t-test was used to compare the means of changes between men and women from baseline to the end of the study. * Significant differences: p < 0.05. HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol, AST, aspartate aminotransferase; ALT, alanine aminotransferase; and hsCRP, high-sensitivity C-reactive protein.
Figure 2Subgroup analysis according to the baseline TG, TC, and LDL-C levels. Change of (a) TG (b) TC and (c) LDL-C in different subgroups. Values are presented as mean ± SD. Unpaired t-test was used to compare the means of baseline and end-of-the study measurements. Significant differences: p < 0.05. TC, total cholesterol; TG, triglycerides; and LDL-C, low-density lipoprotein cholesterol.
Figure 3Plasma (a) TNFα, (b) IL-6, (c) IL-10, (d) leptin, (e) adiponectin, (f) angiotensinogen, (g) MDA, and (h) irisin levels of all participants at baseline (W0) and the end (W6) of the study. Values are presented as mean ± SD. Unpaired t-test was used to compare the means of baseline and end-of-the study measurements. * Significant differences compared to W0 (p < 0.05). TNFα, tumor necrosis factor alpha; IL, interleukin; and MDA, malondialdehyde.
Figure 4Subgroup analysis according to the baseline (a) TNFα, (b) IL-6, and (c) IL-10 levels (